Theranostic Implications of Nanotechnology in Multiple Sclerosis: A Future Perspective

Figure 3

Polymeric nanocarriers in current CNS disorders. Micelle core is promising site for loading insoluble therapeutic agents, while liposome can be targeted by conjugating Ab linker. Fullerene cage surfaces can be functionalized for targeted delivery. Branched dendrimers and nanocapsules are potential nanotheranostic agents.